[NMusers] International Symposium in Quantitative Pharmacology in Drug Development and Regulation, Nanjing, China

Dear colleagues and friends,

 

The International Symposium in Quantitative Pharmacology (ISQP) in Drug Dev=
elopment and Regulation will be held at the International Conference Hotel =
of Nanjing, China from Oct 29 to 31. The theme of this symposium is "Buildi=
ng A Successful Pharmaceutical Industry Through Globalization and Implement=
ation of Quantitative Methodologies for Efficient Drug Development and Appr=
oval".

 

China is becoming an increasingly attractive destination for pharmaceutical=
 research and clinical trials. The ISQP will highlight the challenges and o=
pportunities in this rapidly evolving country. This three - day meeting wil=
l provide an international forum for scientific exchange in recent advancem=
ents in clinical pharmacology and pharmacometrics. It will bring together l=
eading academic, regulatory and industry scientists worldwide to discuss qu=
antitative methodology as a critical tool in decision making during drug de=
velopment and approval. Furthermore, it will offer an avenue to discuss fut=
ure environment for partnering strategy in this very challenging scientific=
 frontier.

 

The conference will consist of three plenary morning sessions and three aft=
ernoon sessions with 2 parallel symposia, one focus on globalization and Ch=
ina, and one on quantitative pharmacology. The preliminary program, registr=
ation and updated information can be found on ISQP Nanjing 2007 website at =
www.qpharmmeeting.com <http://www.qpharmmeeting.com/> . The ISQP is a great=
 opportunity for learning, sharing, exploring and networking.

 

Welcome to ISQP Nanjing 2007!

 

Sponsors =
                            Co-sponsors
Chinese Journal of Clinical Pharmacology and Therapeutics Am=
erican College of Clinical Pharmacology
Chinese Society of Quantitative Pharmacology =
      American Association of Pharmaceutical Scientists
Chinese Society of Pharmacokinetics =
             China Pharmaceutical University
Chinese State FDA =
                       Jiangsu Drug Research and Development Association

This e-mail and its attachments may contain Forest Laboratories, Inc. propr=
ietary information that is privileged, confidential or subject to copyright=
 belonging to Forest Laboratories, Inc. This e-mail is intended solely for =
the use of the individual or entity to which it is addressed. If you are no=
t the intended recipient of this e-mail, or the employee or agent responsib=
le for delivering this e-mail to the intended recipient, you are hereby not=
ified that any dissemination, distribution, copying or action taken in rela=
tion to the contents of and attachments to this e-mail is strictly prohibit=
ed and may be unlawful. If you have received this e-mail in error, please n=
otify the sender immediately and permanently delete the original and any co=
py of this e-mail and any printout.
Received on Wed Aug 08 2007 - 22:51:40 EDT